• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COX-2 通过 HIF-1α/PKM2 通路诱导肝癌细胞凋亡抵抗。

COX-2 induces apoptosis-resistance in hepatocellular carcinoma cells via the HIF-1α/PKM2 pathway.

机构信息

Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China.

出版信息

Int J Mol Med. 2019 Jan;43(1):475-488. doi: 10.3892/ijmm.2018.3936. Epub 2018 Oct 16.

DOI:10.3892/ijmm.2018.3936
PMID:30365092
Abstract

The pyruvate kinase M2 isoform (PKM2) is a key component of aerobic glycolysis and has been reported to regulate apoptosis. However, it is unclear whether PKM2 is involved in cyclooxygenase‑2 (COX‑2) induced apoptosis‑resistance in hepatocellular carcinoma (HCC) cells. In the present study, it was observed that COX‑2 and PKM2 were significantly elevated in hepatocellular carcinoma tissues compared with adjacent liver tissues (P<0.05). Furthermore, their expression was positively associated with worse clinicopathological characteristics, which indicates poor prognosis in patients with HCC. COX‑2 knockdown significantly reduced the expression of PKM2 and hypoxia inducible factor‑1α (HIF‑1α) at the mRNA and protein levels in addition to inhibiting proliferation (P<0.05), whereas apoptosis was notably increased. Furthermore, HIF‑1α and PKM2‑knockdown increased cell apoptosis without inhibiting COX‑2 expression. PKM2 inhibition did not have a marked effect on COX‑2 and HIF‑1α expression. In conclusion, the results of the present study suggested that HIF‑1α/PKM2 pathway‑associated metabolic changes may facilitate COX‑2‑induced apoptosis resistance in HCC cells.

摘要

丙酮酸激酶 M2 同工酶(PKM2)是有氧糖酵解的关键组成部分,据报道其可调节细胞凋亡。然而,PKM2 是否参与环氧合酶-2(COX-2)诱导的肝癌(HCC)细胞凋亡抵抗尚不清楚。在本研究中,与相邻肝组织相比,肝癌组织中 COX-2 和 PKM2 的表达明显升高(P<0.05)。此外,其表达与更差的临床病理特征呈正相关,这表明 HCC 患者预后不良。COX-2 敲低显著降低了 PKM2 和缺氧诱导因子-1α(HIF-1α)的 mRNA 和蛋白水平的表达,同时抑制了增殖(P<0.05),而凋亡明显增加。此外,HIF-1α和 PKM2 敲低在不抑制 COX-2 表达的情况下增加了细胞凋亡。PKM2 抑制对 COX-2 和 HIF-1α 的表达没有显著影响。综上所述,本研究结果表明,HIF-1α/PKM2 通路相关的代谢变化可能有助于 COX-2 诱导的 HCC 细胞凋亡抵抗。

相似文献

1
COX-2 induces apoptosis-resistance in hepatocellular carcinoma cells via the HIF-1α/PKM2 pathway.COX-2 通过 HIF-1α/PKM2 通路诱导肝癌细胞凋亡抵抗。
Int J Mol Med. 2019 Jan;43(1):475-488. doi: 10.3892/ijmm.2018.3936. Epub 2018 Oct 16.
2
HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.热休克蛋白 90 通过调节 Thr-328 磷酸化促进肝癌细胞中 PKM2 的丰度,从而促进细胞糖酵解、增殖,并抑制细胞凋亡。
Mol Cancer. 2017 Dec 20;16(1):178. doi: 10.1186/s12943-017-0748-y.
3
Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis.丙酮酸激酶同工酶 L 向 M2 的转变促进肝癌发生中的代谢重编程。
PLoS One. 2014 Dec 26;9(12):e115036. doi: 10.1371/journal.pone.0115036. eCollection 2014.
4
LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.LNCAROD 通过诱导丙酮酸激酶同工酶 PKM2 激活糖酵解来增强肝癌的恶性程度。
J Exp Clin Cancer Res. 2021 Sep 22;40(1):299. doi: 10.1186/s13046-021-02090-7.
5
PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.丙酮酸激酶M2通过募集髓源性抑制细胞促进转移,并提示肝细胞癌预后不良。
Oncotarget. 2015 Jan 20;6(2):846-61. doi: 10.18632/oncotarget.2749.
6
Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis.辛伐他汀通过抑制 HIF-1α/PPAR-γ/PKM2 介导的糖酵解使肝癌细胞对索拉非尼重新敏感。
J Exp Clin Cancer Res. 2020 Jan 30;39(1):24. doi: 10.1186/s13046-020-1528-x.
7
PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma.原花青素 B2 通过抑制肝癌作用于 PKM2。
J Exp Clin Cancer Res. 2019 May 17;38(1):204. doi: 10.1186/s13046-019-1194-z.
8
Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.丙酮酸激酶M2亚型抑制肝癌细胞迁移的机制
World J Gastroenterol. 2015 Aug 14;21(30):9093-102. doi: 10.3748/wjg.v21.i30.9093.
9
Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma.丙酮酸激酶M2通过调节Bim稳定性来预防细胞凋亡,并与肝细胞癌的不良预后相关。
Oncotarget. 2015 Mar 30;6(9):6570-83. doi: 10.18632/oncotarget.3262.
10
miR-4417 Targets Tripartite Motif-Containing 35 (TRIM35) and Regulates Pyruvate Kinase Muscle 2 (PKM2) Phosphorylation to Promote Proliferation and Suppress Apoptosis in Hepatocellular Carcinoma Cells.微小RNA-4417靶向含三联基序蛋白35(TRIM35)并调节丙酮酸激酶M2型(PKM2)磷酸化,以促进肝癌细胞增殖并抑制其凋亡。
Med Sci Monit. 2017 Apr 10;23:1741-1750. doi: 10.12659/msm.900296.

引用本文的文献

1
PKM2-driven metabolic reprogramming in digestive system tumors: mechanisms, therapeutic advances, and clinical challenges.丙酮酸激酶M2驱动的消化系统肿瘤代谢重编程:机制、治疗进展及临床挑战
Front Immunol. 2025 Aug 6;16:1634786. doi: 10.3389/fimmu.2025.1634786. eCollection 2025.
2
Fucoidan-Based Gold Nanoparticles: Antioxidant and Anticancer Potential from and .基于岩藻依聚糖的金纳米粒子:来自[具体来源]的抗氧化和抗癌潜力。 (你原文中“from and.”表述不太完整准确,推测可能是这样补充翻译)
Pharmaceutics. 2025 Jun 25;17(7):826. doi: 10.3390/pharmaceutics17070826.
3
Dihydroartemisinin suppresses COX-2-mediated apoptosis resistance in hepatocellular carcinoma under endoplasmic reticulum stress.
双氢青蒿素在内质网应激条件下抑制肝细胞癌中COX-2介导的凋亡抵抗。
Cytotechnology. 2025 Apr;77(2):59. doi: 10.1007/s10616-025-00717-7. Epub 2025 Feb 13.
4
Thiazolidinedione derivatives: emerging role in cancer therapy.噻唑烷二酮衍生物:在癌症治疗中的新作用。
Mol Divers. 2025 Feb 3. doi: 10.1007/s11030-024-11093-3.
5
[Research progress on ferroptosis regulation in tumor immunity of hepatocellular carcinoma].[肝细胞癌肿瘤免疫中铁死亡调节的研究进展]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Dec 25;53(6):715-725. doi: 10.3724/zdxbyxb-2024-0117.
6
Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside.免疫抑制性肿瘤微环境在肝细胞癌进展、转移及治疗中的作用:从实验台到临床应用
Exp Hematol Oncol. 2024 Aug 1;13(1):72. doi: 10.1186/s40164-024-00539-x.
7
The COX-2/PGE2 Response Pathway Upregulates Radioresistance in A549 Human Lung Cancer Cells through Radiation-Induced Bystander Signaling.COX-2/PGE2反应通路通过辐射诱导的旁观者信号上调A549人肺癌细胞的放射抗性。
Biology (Basel). 2023 Oct 25;12(11):1368. doi: 10.3390/biology12111368.
8
Targeting ferroptosis in hepatocellular carcinoma.针对肝细胞癌中的铁死亡
Hepatol Int. 2024 Feb;18(1):32-49. doi: 10.1007/s12072-023-10593-y. Epub 2023 Oct 26.
9
Activation of the JNK/COX-2/HIF-1α axis promotes M1 macrophage via glycolytic shift in HIV-1 infection.HIV-1 感染通过糖酵解途径激活 JNK/COX-2/HIF-1α 轴促进 M1 型巨噬细胞极化。
Life Sci Alliance. 2023 Oct 5;6(12). doi: 10.26508/lsa.202302148. Print 2023 Dec.
10
Cannabis sativa demonstrates anti-hepatocellular carcinoma potentials in animal model: in silico and in vivo studies of the involvement of Akt.大麻在动物模型中显示出抗肝细胞癌的潜力:Akt参与的计算机模拟和体内研究
J Cannabis Res. 2023 Jul 12;5(1):27. doi: 10.1186/s42238-023-00190-z.